Lexaria Enters a New Pharmaceutical Agreement for DehydraTECH

Third pharmaceutical company relationship entered KELOWNA, BC / ACCESS Newswire / November 4, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces that it has entered …